Zobrazeno 1 - 10
of 44
pro vyhledávání: '"David Herrero-Martin"'
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Supplementary Table S2. Small-molecule library.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49737467db8c08d90decb5f81641fa04
https://doi.org/10.1158/0008-5472.22406303
https://doi.org/10.1158/0008-5472.22406303
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Pediatric tumors harbor very low numbers of somatic mutations and therefore offer few targets to improve therapeutic management with targeted drugs. In particular, outcomes remain dismal for patients with metastatic alveolar rhabdomyosarcoma (aRMS),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db77c9439699b7ea833a8851f179e2d
https://doi.org/10.1158/0008-5472.c.6507038
https://doi.org/10.1158/0008-5472.c.6507038
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Supplementary Figure Legends. Legend for Supplementary Figures S1-S7.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd2f04dc5f923c21648c84f408f6dcac
https://doi.org/10.1158/0008-5472.22406315.v1
https://doi.org/10.1158/0008-5472.22406315.v1
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Supplementary Materials and Methods. Description of additional methods and procedures used in the study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589222c131d0d9ec64e0f8537183cdbb
https://doi.org/10.1158/0008-5472.22406309.v1
https://doi.org/10.1158/0008-5472.22406309.v1
Autor:
Olga Almacellas-Rabaiget, Santiago Rello-Varona, Paola Monaco, O.M. Tirado, Juan Huertas-Martinez, Susana Maqueda-Marcos, Silvia Garcia-Monclús, Isabel Fabra-Heredia, Roser López-Alemany, Enrique de Álava, Mariona Chicón-Bosch, David Herrero-Martin, Paloma H. Giangrande
Publikováno v:
Cancer Letters
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC. Repositorio Institucional del CSIC
instname
Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in childhood and adolescence. Patients with the most aggressive histological variant have an unfavorable prognosis due to a high metastasis incidence. Lysyl oxidase-like 2 (LOXL2) is a
Autor:
Santi Rello-Varona, Olga Almacellas-Rabaiget, Roser López-Alemany, Jaume Mora, Piedad Alba-Pavón, Enrique de Álava, Juan Huertas-Martinez, Lourdes Hontecillas-Prieto, Silvia Garcia-Monclús, David Herrero-Martin, Laura Lagares-Tena, Paloma H. Giangrande, O.M. Tirado
Publikováno v:
International Journal of Cancer. 143:1188-1201
Ewing sarcoma (ES) is the second most common bone malignancy affecting children and young adults with poor prognosis due to high metastasis incidence. Our group previously described that EphA2, a tyrosine kinase receptor, promotes angiogenesis in Ewi
Autor:
David Herrero-Martin, Argyro Fourtouna, Stephan Niedan, Lucia T. Riedmann, Raphaela Schwentner, Dave N. T. Aryee
Publikováno v:
Sarcoma, Vol 2011 (2011)
Ewing's sarcoma family tumors (ESFT) are characterized by specific chromosomal translocations, which give rise to EWS-ETS chimeric proteins. These aberrant transcription factors are the main pathogenic drivers of ESFT. Elucidation of the factors infl
Externí odkaz:
https://doaj.org/article/559cd7bed7fd43b9a12f5b1c35806026
Autor:
Roser López-Alemany, Oscar M. Tirado, Juan Huertas-Martinez, Silvia Garcia-Monclús, Carlos Rodriguez-Galindo, Olga Almacellas-Rabaiget, Santiago Rello-Varona, Miguel Sáinz-Jaspeado, David Herrero-Martin, Laura Lagares-Tena, Silvia Mateo-Lozano
Publikováno v:
Oncotarget
// Laura Lagares-Tena 1 , Silvia Garcia-Monclus 1 , Roser Lopez-Alemany 1 , Olga Almacellas-Rabaiget 1 , Juan Huertas-Martinez 1 , Miguel Sainz-Jaspeado 1 , Silvia Mateo-Lozano 2 , Carlos Rodriguez-Galindo 3 , Santiago Rello-Varona 1 , David Herrero-
Autor:
Oscar M. Tirado, Cristina Muñoz-Pinedo, Roser López-Alemany, David Herrero-Martin, Santiago Rello-Varona
Publikováno v:
Cancer Research. 75:913-917
During the last decades, the knowledge of cell death mechanisms involved in anticancer therapy has grown exponentially. However, in many studies, cell death is still described in an incomplete manner. The frequent use of indirect proliferation assays
Autor:
Regina Hecker, Ewa Koscielniak, Peter K. Bode, Maria E. Gierisch, David Herrero-Martin, Bernd Blank, Laura A. Lopez-Garcia, Marco Wachtel, Verena Thalhammer, Dominik Laubscher, Paolo Nanni, Beat W. Schäfer
Publikováno v:
Cancer research
Pediatric tumors harbor very low numbers of somatic mutations and therefore offer few targets to improve therapeutic management with targeted drugs. In particular, outcomes remain dismal for patients with metastatic alveolar rhabdomyosarcoma (aRMS),